GEN1042 DP, PEMBROLIZUMAB clinical trials

A Phase 1 Dose Finding and Phase 2 Randomized, Open-Label Trial to Evaluate the Safety and Clinical Activity of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors

This study is looking at new ways to treat advanced cancers that have spread. It combines two types of treatment, GEN1042 DP and Pembrolizumab, to see if they are safe and effective. Researchers want to understand how these treatments work together.